Article: When used with nicotine replacement therapy and cognitive-behavioral counseling, bupropion (Zyban[R]) did not improve one-year smoking cessation rates.(POSTSCRIPTS)(Brief Article)

WHEN USED WITH NICOTINE REPLACEMENT THERAPY and cognitive-behavioral counseling, bupropion (Zyban[R]) did not improve one-year smoking cessation rates, but it did appear to reduce several withdrawal symptoms.

In a study published in the Archives of Internal Medicine (2004;164 September 13), current smokers older than 20 years of age who did not have major depression or a recent history of alcohol abuse were treated for seven weeks with either bupropion or a placebo in addition to other therapies. Cigarette discontinuation rates were ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!